Article L1123-13 of the French Public Health Code
If the research is to be carried out in one or more public or private establishments, the sponsor must inform the director(s) of these establishments before the research is carried out.
If the research is to be carried out in one or more public or private establishments, the sponsor must inform the director(s) of these establishments before the research is carried out.
The procedures for applying the provisions of this chapter are determined by decree in the Conseil d’Etat, and in particular : 1° The composition and conditions of approval, financing, operation and appointment of the members of the Committees for the Protection of Individuals, as well as the nature of the information that must be communicated to them by the sponsor and on which they are called to give their opinion;…
Subject to the provisions of this chapter, the provisions of chapters III, V and VI of this title apply respectively to research involving the human person, clinical investigations and performance studies which are classified as a national defence secret within the meaning ofarticle 413-9 of the Criminal Code and which are carried out for protection purposes. Such research, clinical investigations and performance studies are referred to as “research, clinical investigations…
I.- For research, clinical investigations or performance studies involving national defence secrets, the sponsor submits the project for the opinion of a specific committee for the protection of individuals, called the “Defence and National Security Committee for the Protection of Individuals”, approved by the Prime Minister on the proposal of the Minister for Defence and after obtaining the opinion of the Minister for Health. The Prime Minister alone is competent…
When the authority designated in article L. 1123-12 or in II of articles L. 1125-1 and L. 1126-1 does not have agents with the level of clearance required for national defence confidentiality, given the level of classification of the research involving the human person, the clinical investigation or the performance study that is envisaged, the competent authority, within the meaning of this article, is the Prime Minister.
Any substantial modification at the initiative of the sponsor of a research project, clinical investigation or performance study covered by national defence confidentiality must obtain, prior to its implementation, a favourable opinion from the Defence and National Security Committee for the Protection of Individuals mentioned in I of Article L. 1123-16 and, in the case of research mentioned in 1° of article L. 1121-1, clinical investigations mentioned in II of…
For research, clinical investigations or performance studies covered by national defence confidentiality, the sponsor must notify the competent authority of all relevant information relating to the safety of the research, clinical investigation or performance study. Where such research, clinical investigations or performance studies involve persons who have no medical condition and who voluntarily undergo such research, clinical investigations or performance studies, the sponsor shall also notify the Minister for Defence.
The procedures for applying this chapter are defined, unless otherwise provided, by decree in the Conseil d’Etat, in particular : 1° The conditions for approval, funding, operation and appointment of the members of the Committee for the Protection of Individuals – Defence and National Security, as well as the nature of the information that must be communicated to it by the sponsor and on which it is required to give…
I.- Clinical trials of medicinal products are governed by the provisions of Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014. The competent authority for carrying out the assessment of Part I of the assessment report provided for in Article 6 of this Regulation is the National Agency for the Safety of Medicines and Health Products. The assessment of Part II provided for…
I.-The clinical investigations of the devices mentioned in Article 1 of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 are governed by the provisions of the aforementioned Regulation (EU) and the provisions of this chapter. II-The competent authority for carrying out the scientific examination as part of the assessment of the clinical investigation request provided for in Article 62(3) and referred to in…
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Resources
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Useful links
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.
All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.